An inhibitor of cardiac late sodium current
Related Products
Isomer(s)
20682R-(–)-Flecainide
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Flecainide (acetate)

Item No. 20388

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-benzamide, monoacetate
CAS Number
54143-56-5
Molecular Formula
C17H20F6N2O3 • C2H4O2
Formula Weight
474.4
Purity
≥98%
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMSO: 100 mMWater: 25 mM
λmax
261 nm
SMILES
O=C(NCC1CCCCN1)C2=C(OCC(F)(F)F)C=CC(OCC(F)(F)F)=C2.OC(C)=O
InChi Code
InChI=1S/C17H20F6N2O3.C2H4O2/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11;1-2(3)4/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26);1H3,(H,3,4)
InChi Key
RKXNZRPQSOPPRN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $36

    Add

    10 mg

    $68

    Add

    25 mg

    $153

    Add

    50 mg

    $268

    Add
    Product Description

    Flecainide is an inhibitor of cardiac late sodium current (INa; IC50 = 3.4 µM) and delayed-rectifier potassium current (IKr; IC50 = 1.5 µM).1,2,3 Formulations containing flecainide have been used in the treatment of arrhythmias and sodium-dependent calcium overload associated with myocardial ischemia and heart failure.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ramos, E., and O'Leary, M.E. State-dependent trapping of flecainide in the cardiac sodium channel. J. Physiol. 560(Pt. 1), 37-49 (2004).

    2. Belardinelli, L., Liu, G., Smith-Maxwell, C., et al. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias. J. Pharmacol. Exp. Ther. 344(1), 23-32 (2013).

    3. Gutman, G.A., Chandy, K.G., Grissmer, S., et al. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 57(4), 473-508 (2005).